PFE vs. TECB
PFE (Pfizer Inc.) is a stock, while TECB (iShares U.S. Tech Breakthrough Multisector ETF) is Technology Equities fund tracking the NYSE FactSet U.S. Tech Breakthrough Index. Over the past 5 years, PFE returned -4.86%/yr vs 11.80%/yr for TECB. At a 0.21 correlation, their price movements are largely independent.
Performance
PFE vs. TECB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PFE achieves a 2.73% return, which is significantly lower than TECB's 15.26% return.
PFE
- 1D
- -1.20%
- 1M
- -1.82%
- 6M
- -0.27%
- YTD
- 2.73%
- 1Y
- 8.21%
- 3Y*
- -7.26%
- 5Y*
- -4.86%
- 10Y*
- 1.03%
- ALL TIME*
- 9.04%
TECB
- 1D
- -0.07%
- 1M
- -1.77%
- 6M
- 15.72%
- YTD
- 15.26%
- 1Y
- 21.27%
- 3Y*
- 22.33%
- 5Y*
- 11.80%
- 10Y*
- —
- ALL TIME*
- 17.40%
PFE vs. TECB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 2.73% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.84% |
TECB iShares U.S. Tech Breakthrough Multisector ETF | 15.26% | 14.86% | 24.38% | 57.53% | -34.39% | 19.60% | 39.90% |
Correlation
The correlation between PFE and TECB is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jan 10, 2020 | 0.21 |
The correlation between PFE and TECB shifts across timeframes, from 0.10 (1 year) to 0.21 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PFE vs. TECB — Risk / Return Rank
PFE
TECB
PFE vs. TECB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and iShares U.S. Tech Breakthrough Multisector ETF (TECB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PFE | TECB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.81 | ||
| Sortino ratioReturn per unit of downside risk | -0.96 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.20 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 0.52 | 1.32 | -0.79 |
| Martin ratioReturn relative to average drawdown | 1.21 | 3.69 | -2.48 |
Loading charts...
Drawdowns
PFE vs. TECB - Drawdown Comparison
The maximum PFE drawdown since its inception was -69.24%, which is greater than TECB's maximum drawdown of -41.62%. Use the drawdown chart below to compare losses from any high point for PFE and TECB.
Loading charts...
Drawdown Indicators
| PFE | TECB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.24% | -41.62% | -27.62% |
Max Drawdown (1Y)Largest decline over 1 year | -15.72% | -16.24% | +0.52% |
Max Drawdown (3Y)Largest decline over 3 years | -36.38% | -23.91% | -12.47% |
Max Drawdown (5Y)Largest decline over 5 years | -58.96% | -41.62% | -17.34% |
Max Drawdown (10Y)Largest decline over 10 years | -58.96% | — | — |
Current DrawdownCurrent decline from peak | -48.71% | -5.41% | -43.30% |
Average DrawdownAverage peak-to-trough decline | -22.95% | -10.07% | -12.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.80% | 5.77% | +1.03% |
Volatility
PFE vs. TECB - Volatility Comparison
Pfizer Inc. (PFE) has a higher volatility of 7.38% compared to iShares U.S. Tech Breakthrough Multisector ETF (TECB) at 5.22%. This indicates that PFE's price experiences larger fluctuations and is considered to be riskier than TECB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PFE | TECB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.38% | 5.22% | +2.16% |
Volatility (6M)Calculated over the trailing 6-month period | 15.35% | 15.05% | +0.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.30% | 18.57% | +5.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.63% | 23.75% | +1.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.97% | 25.34% | -1.37% |
Dividends
PFE vs. TECB - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 6.95%, more than TECB's 0.31% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 6.95% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
TECB iShares U.S. Tech Breakthrough Multisector ETF | 0.31% | 0.33% | 0.35% | 0.23% | 0.61% | 0.35% | 0.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
PFE and TECB have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PFE has higher volatility (7.38%) compared to TECB (5.22%). In terms of maximum drawdown, PFE dropped -69.24% vs TECB's -41.62%.
TECB currently has the higher Sharpe Ratio (1.15 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PFE and TECB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer